Charles Schwab Investment Management Inc Igm Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$527 Billion
Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 157,843 shares of IGMS stock, worth $194,146. This represents 0.0% of its overall portfolio holdings.

Number of Shares

157,843

Previous 148,402 6.36%

Holding current value

$194,146

Previous $2.45 Million 60.72%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$6.05 - $17.83 $57,118 - $168,333	9,441 Added 6.36%	157,843 $964,000
Q3 2024 Nov 12, 2024	BUY	$6.28 - $17.68 $100,932 - $284,152	16,072 Added 12.15%	148,402 $2.45 Million
Q2 2024 Aug 12, 2024	BUY	$6.51 - $11.47 $72,990 - $128,601	11,212 Added 9.26%	132,330 $909,000
Q1 2024 May 08, 2024	BUY	$8.68 - $17.36 $2,612 - $5,225	301 Added 0.25%	121,118 $1.17 Million
Q4 2023 Feb 06, 2024	BUY	$3.94 - $8.79 $82,944 - $185,047	21,052 Added 21.1%	120,817 $1 Million
Q3 2023 Nov 08, 2023	BUY	$6.66 - $10.64 $16,463 - $26,302	2,472 Added 2.54%	99,765 $833,000
Q2 2023 Aug 09, 2023	BUY	$8.86 - $14.0 $30,806 - $48,678	3,477 Added 3.71%	97,293 $898,000
Q1 2023 May 11, 2023	BUY	$13.74 - $25.76 $308,737 - $578,827	22,470 Added 31.49%	93,816 $1.29 Million
Q4 2022 Feb 13, 2023	BUY	$15.45 - $26.02 $19,312 - $32,525	1,250 Added 1.78%	71,346 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $74,185 - $129,945	4,811 Added 7.37%	70,096 $1.59 Million
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $495,475 - $952,119	-37,338 Reduced 36.38%	65,285 $1.18 Million
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $610,636 - $1.35 Million	45,502 Added 79.66%	102,623 $2.74 Million
Q4 2021 Feb 11, 2022	BUY	$27.59 - $66.39 $34,597 - $83,253	1,254 Added 2.24%	57,121 $1.68 Million
Q3 2021 Nov 16, 2021	BUY	$65.76 - $90.65 $327,879 - $451,980	4,986 Added 9.8%	55,867 $3.67 Million
Q2 2021 Aug 16, 2021	BUY	$57.98 - $96.6 $107,147 - $178,516	1,848 Added 3.77%	50,881 $4.23 Million
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $261,480 - $442,974	3,654 Added 8.05%	49,033 $3.76 Million
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $25,506 - $61,886	-538 Reduced 1.17%	45,379 $4.01 Million
Q3 2020 Nov 13, 2020	SELL	$43.0 - $84.01 $970,553 - $1.9 Million	-22,571 Reduced 32.96%	45,917 $3.39 Million
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $461,597 - $676,739	8,998 Added 15.13%	68,488 $5 Million
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $33,085 - $77,437	1,050 Added 1.8%	59,490 $3.34 Million
Q4 2019 Feb 07, 2020	BUY	$17.25 - $49.51 $1.01 Million - $2.89 Million	58,440 New	58,440 $2.23 Million

Others Institutions Holding IGMS

# of Institutions

Shares Held

19.4M

Call Options Held

61.3K

Put Options Held

36.7K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $35.6M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Igm Biosciences, Inc. Transaction History